At Cleyrop, we are convinced that digital transformation can offer unprecedented opportunities to meet the challenges facing public organizations.

Our collaboration with ANSM (Agence nationale de sécurité du médicament et des produits de santé) is a perfect illustration of this.

Together, we are exploring the potential of generative artificial intelligence to enhance regulatory capabilities, improve decision-making and guarantee optimal transparency in public health, while complying with the highest data security requirements.

A Visionary Project Supported by Concrete Use Cases

Our partnership with ANSM is part of an ambitious project to deploy a secure, scalable and user-friendly generative AI platform. The initial phase of this project focuses on two key use cases:

1. Performance appraisal analysis for the HR team
   Using our platform, AI analyzes structured and unstructured data from appraisal feedback, identifies trends and simplifies annual appraisal processes.
2. Detection of risks in Summaries of Product Characteristics (SPCs) for the surveillance department
   By analyzing SPCs, in particular pictograms relating to pregnancy, our solution highlights potential risks to reinforce pharmacovigilance.

Our Strategic Objectives

In working with ANSM, we are pursuing several major objectives:

• Increase productivity: Automate time-consuming processes such as HR feedback analysis and ROI risk detection.
• Improve Decision Making: Provide actionable insights to enable teams to focus on strategic priorities.
• Ensuring security and compliance: operating data in an environment that complies with the most stringent standards, particularly in terms of health and HR.
• Preparing for the future: Creating an adaptable, scalable solution to meet future needs.
• ‍

Want to find out more about our AI and Data solutions? Contact us to find out how we can support your strategic projects.

‍